سوق رصد الجلوكوز في الدم في الشرق الأوسط وأفريقيا - النمو ، والاتجاهات ، وتأثير كوفيد -19 ، والتوقعات (2022 - 2027)

Table of Contents

1. 1. INTRODUCTION

   1. 1.1 Study Assumptions

   2. 1.2 Scope of the Study

2. 2. RESEARCH METHODOLOGY

3. 3. EXECUTIVE SUMMARY

4. 4. MARKET DYNAMICS

   1. 4.1 Market Overview

   2. 4.2 Market Drivers

   3. 4.3 Market Restraints

   4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

5. 5. MARKET SEGMENTATION

   1. 5.1 Self-monitoring Blood Glucose

      1. 5.1.1 By Component (Value and Volume, 2016 - 2026)

         1. 5.1.1.1 Glucometer Devices

         2. 5.1.1.2 Test Strips

         3. 5.1.1.3 Lancets

   2. 5.2 Continuous Glucose Monitoring

      1. 5.2.1 By Component (Value and Volume, 2016 - 2026)

         1. 5.2.1.1 Sensors

         2. 5.2.1.2 Durables

   3. 5.3 By Geography

      1. 5.3.1 Middle-East and Africa

         1. 5.3.1.1 Saudi Arabia (Value and Volume, 2016 - 2026)

            1. 5.3.1.1.1 Self-monitoring Blood Glucose

               1. 5.3.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.1.2 Continuous Glucose Monitoring

               1. 5.3.1.1.2.1 By Component (Sensors and Durables)

         2. 5.3.1.2 Iran (Value and Volume, 2016 - 2026)

            1. 5.3.1.2.1 Self-monitoring Blood Glucose

               1. 5.3.1.2.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.2.2 Continuous Glucose Monitoring

               1. 5.3.1.2.2.1 By Component (Sensors and Durables)

         3. 5.3.1.3 Egypt (Value and Volume, 2016 - 2026)

            1. 5.3.1.3.1 Self-monitoring Blood Glucose

               1. 5.3.1.3.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.3.2 Continuous Glucose Monitoring

               1. 5.3.1.3.2.1 By Component (Sensors and Durables)

         4. 5.3.1.4 Oman (Value and Volume, 2016 - 2026)

            1. 5.3.1.4.1 Self-monitoring Blood Glucose

               1. 5.3.1.4.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.4.2 Continuous Glucose Monitoring

               1. 5.3.1.4.2.1 By Component (Sensors and Durables)

         5. 5.3.1.5 South Africa (Value and Volume, 2016 - 2026)

            1. 5.3.1.5.1 Self-monitoring Blood Glucose

               1. 5.3.1.5.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.5.2 Continuous Glucose Monitoring

               1. 5.3.1.5.2.1 By Component (Sensors and Durables)

         6. 5.3.1.6 Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)

            1. 5.3.1.6.1 Self-monitoring Blood Glucose

               1. 5.3.1.6.1.1 By Component (Glucometer Device, Test strips, Lancets)

            2. 5.3.1.6.2 Continuous Glucose Monitoring

               1. 5.3.1.6.2.1 By Component (Sensors and Durables)

6. 6. MARKET INDICATORS

   1. 6.1 Type-1 Diabetes population (2016 - 2026)

   2. 6.2 Type-2 Diabetes population (2016 - 2026)

7. 7. COMPETITIVE LANDSCAPE

   1. 7.1 Company Profiles

      1. 7.1.1 Abbott

      2. 7.1.2 F. Hoffmann-La Roche AG

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Dexcom

      5. 7.1.5 Medtronics

      6. 7.1.6 Agamatrix Inc.

      7. 7.1.7 Bionime Corporation

      8. 7.1.8 Acon

      9. 7.1.9 Medisana

      10. 7.1.10 Trivida

      11. 7.1.11 I-SENS

      12. 7.1.12 Ascensia

      13. 7.1.13 Rossmax

8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS